drugset / Trial / NCT04823962

Effect of rhGM-CSF on the Healing of Venous Leg Ulcers

NCT04823962

Phase 2 Unknown 6 enrolled Reponex Pharmaceuticals A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to examine whether local administration of the growth factor rhGM-CSF incorporated into a hydrogel, can accelerate wound healing when applied to venous leg ulcers, and whether this is safe.

Timeline

Start
2021-03-11
Primary completion
2023-12-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Molgramostim Protein / enzyme biologic Topical

Indications